SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-04-003065
Filing Date
2004-03-26
Accepted
2004-03-26 13:47:56
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 GTX, INC. - FORM 10-K g88027e10vk.htm 10-K 716456
3 EX-14.1 CODE OF ETHICS g88027exv14w1.txt EX-14.1 44976
4 EX-23.1 CONSENT OF ERNST & YOUNG LLP g88027exv23w1.txt EX-23.1 797
5 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g88027exv31w1.txt EX-31.1 3731
6 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g88027exv31w2.txt EX-31.2 3755
7 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g88027exv32w1.txt EX-32.1 1124
8 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO g88027exv32w2.txt EX-32.2 1117
  Complete submission text file 0000950144-04-003065.txt   774318
Mailing Address 3 N DUNLAP 3RD FLOOR VAN VIEEN BLDG MEMPHIS TN 38163
Business Address 3 NORTH DUNLAP AVE 3RD FL VAN VLEET BUILDING MEMPHIS TN 38163 901-523-9700
GTX INC /DE/ (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-50549 | Film No.: 04692223
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences